stars 1 stars 2 stars 3

Kymanox (‘ki-mah-noks’) is a professional services and consulting company specializing in combination products and drug-device delivery technologies. We provide engineering, scientific, quality, regulatory, project management, formulation, CMC, and technical operations support to the biologics, pharmaceutical, medical device, and combination product industries. Since 2004, we’ve helped companies, from Fortune 100 leaders to nimble start-ups, bring drugs and delivery devices together into safe, effective, patient-ready products. Our teams bridge pharmaceutical and device disciplines, guiding programs from early concept through design, development, verification, regulatory submission, and commercial launch. 300+ global clients 200+ product launches supported Work delivered in 20+ countries Combination Products & Drug Delivery We bring deep expertise in drug-device delivery technologies, including prefilled syringes, autoinjectors, pen injectors, on-body injectors, and inhalers. Our work spans design controls, risk management, human factors engineering, verification and testing, container closure integration, regulatory strategy, technology transfer, and manufacturing readiness. Quality & Regulatory We help life science organizations build and improve quality management systems, close compliance gaps, strengthen inspection readiness, and prepare for Pre-Approval Inspections (PAIs). Our teams also provide regulatory strategy and support through critical development milestones. KymaBridge Platform KymaBridge, our online drug delivery device platform, connects drug sponsors with device suppliers and organizes key device information in one place. Kymanox means Ideal Knowledge Transfer. Follow us for industry insights, regulatory updates, and expert perspectives on combination products, quality, and modern medicine… because patients deserve better.

Website http://www.kymanox.com
Revenue $23.3 million
Funding $1 million
Employees 212 (163 on RocketReach)
Founded 2004
Address 430 Davis Drive Suite 300, Morrisville, North Carolina 27560-6802, US
Phone +1 919-246-4896
Technologies
Industry Professional Services, Drug Manufacturing & Research, Technical Project Management, Pharmaceuticals, Process Operations, Healthcare, Engineering, Quality / Compliance / Regulatory, Commissioning and Validation, Automation and Software, Training, FDA PAI Assistance, Sustainability
Web Rank 15 Million
Keywords Pharmaceutical Development, Innovation, Solutions, Drug Development, Collaboration, Biotechnology, Quality Assurance, Process Development, Manufacturing, Pharmaceutical Consulting, Drug Delivery, Formulation Development, Regulatory Affairs, Contract Manufacturing, Analytical Testing, Compliance, Clinical Trials, Validation
Competitors Veristat, Celerion, PPD, Medpace, ICON plc, Research Pharmaceutical Services, CROMSOURCE, Labcorp, Syneos Health, Charles River Laboratories +31 more (view full list)
SIC SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies

Kymanox Questions

The Kymanox annual revenue was $23.3 million in 2026.

Evan Edwards is the CEO of Kymanox.

163 people are employed at Kymanox.

Kymanox is based in Morrisville, North Carolina.

The NAICS codes for Kymanox are [32541, 3254, 541, 54, 32, 325].

The SIC codes for Kymanox are [283, 28].

Top Kymanox Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users